Delivery Order SPE2DE21D0005-SPE2D625F9TR3
Award Date 7/31/25
Potential Completion Date 8/5/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Organogenesis Inc. was awarded a $8,500 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by July 28, 2025. The work will be performed at Organogenesis' headquarters in Canton, Massachusetts. No set-aside designation was utilized for this award, indicating...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,274.00 to Organogenesis Inc. for the supply of PURAPLY Micronized 500mg, an advanced wound care product. The contract, awarded on July 23, 2025, with an ultimate completion date of July 28, 2025, utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation. Organogenesis, a regenerative medicine company headquartered in Canton, Massachusetts, will perform the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
- This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
- This is a delivery order contract awarded to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of PURAPLY MICRONIZED, 500MG, a wound care product, with a ceiling value of $3,008. The contract has a fixed price with economic price adjustment pricing type and a completion date of June 10, 2025. Organogenesis is a key supplier of medical products, including skin substitutes,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products headquartered in Canton, Massachusetts. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment and has a period of performance through March 6, 2025. This award is not associated with a set-aside designation,...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment, with a completion date of March 20, 2025. The contract does not have a set-aside...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded Organogenesis Inc., a leading regenerative medicine company, a $1,118.88 fixed-price delivery order contract for PURAPLY AM (2x2) 4 SQ CM wound dressings. This is not a set-aside contract. Organogenesis is a for-profit manufacturer that has been awarded numerous prime federal contracts to provide wound care products, surgical implants, and tissue regeneration solutions to government agencies, including the Department of...
- This federal contract award to Organogenesis Inc. is a $2,200.00 fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical for the product PURAPLY AM XT 4.91X4.91. The award has an ultimate completion date of July 5, 2024 and does not utilize a set-aside designation. Organogenesis Inc. is a leading regenerative medicine company that has been awarded numerous contracts with the Department of Defense (DoD) and Department of Veterans Affairs (VA) to supply...